Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.733
H.R.733: Recalcitrant Cancer Research Act of 2012
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about health
- Introduced Feb. 16, 2011
- Latest Major Action Sept. 20, 2012
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
294 (181 Democrats, 113 Republicans)
Bill Summary
Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes: (1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Energy and Commerce.
|
|
Referred to the Subcommittee on Health.
|
|
Subcommittee Consideration and Mark-up Session Held.
|
|
Forwarded by Subcommittee to Full Committee (Amended) .
|
|
Mr. Pitts moved to suspend the rules and pass the bill, as amended.
|
|
Considered under suspension of the rules.
|
|
DEBATE - The House proceeded with forty minutes of debate on H.R. 733.
|
|
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
|
|
Motion to reconsider laid on the table Agreed to without objection.
|
|
The title of the measure was amended. Agreed to without objection.
|
|
Received in the Senate.
|
|
Feb. 16, 2011 |
Introduced in the House by Anna G. Eshoo (D-Calif.) |